{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T23:38:27Z","timestamp":1783726707906,"version":"3.55.0"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2016,11,16]],"date-time":"2016-11-16T00:00:00Z","timestamp":1479254400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0166484","type":"journal-article","created":{"date-parts":[[2016,11,16]],"date-time":"2016-11-16T18:37:33Z","timestamp":1479321453000},"page":"e0166484","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Skin Globotriaosylceramide 3 Load Is Increased in Men with Advanced Fabry Disease"],"prefix":"10.1371","volume":"11","author":[{"given":"Nurcan","family":"\u00dc\u00e7eyler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Schr\u00f6ter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waldemar","family":"Kafke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Wanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Weidemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Sommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,11,16]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pharmthera.2009.01.003","article-title":"Fabry disease","volume":"122","author":"R Schiffmann","year":"2009","journal-title":"Pharmacol Ther"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0923-1811(98)00032-2","article-title":"The ultrastructural characteristics of eccrine sweat glands in a Fabry disease patient with hypohidrosis","volume":"18","author":"LM Lao","year":"1998","journal-title":"J Dermatol Sci"},{"key":"ref3","first-page":"842","article-title":"The ultrastructural study in a case of Fabry disease","volume":"85","author":"P Palungwachira","year":"2002","journal-title":"J Med Assoc Thai"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1365-2133.2005.06732.x","article-title":"Immunoelectron-microscopic detection of globotriaosylceramide accumulated in the skin of patients with Fabry disease","volume":"153","author":"T Kanekura","year":"2005","journal-title":"Br J Dermatol"},{"key":"ref5","first-page":"41","article-title":"Ultrastructure of lipid bodies and lysosomes in the skin in Fabry's disease (angiokeratoma corporis diffusum)","volume":"28","author":"PJ van Mullem","year":"1972","journal-title":"Arch Belg Dermatol Syphiligr"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00428-007-0468-6","article-title":"Cellular and tissue localization of globotriaosylceramide in Fabry disease","volume":"451","author":"H Askari","year":"2007","journal-title":"Virchows Arch"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/jcp.25072","article-title":"Characterization of Human Dermal Fibroblasts in Fabry Disease","volume":"231","author":"J Lakoma","year":"2016","journal-title":"J Cell Physiol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"e0124987","DOI":"10.1371\/journal.pone.0124987","article-title":"Characterization of early disease status in treatment-naive male paediatric patients with fabry disease enrolled in a randomized clinical trial","volume":"10","author":"FA Wijburg","year":"2015","journal-title":"PLoS ONE"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s00401-005-0026-8","article-title":"Fabry disease: an ultrastructural comparative study of skin in hemizygous and heterozygous patients","volume":"111","author":"C Navarro","year":"2006","journal-title":"Acta Neuropathol (Berl)"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/j.0022-202X.2004.22425.x","article-title":"Monitoring the 3-year efficacy of enzyme replacement therapy in fabry disease by repeated skin biopsies","volume":"122","author":"BL Thurberg","year":"2004","journal-title":"J Invest Dermatol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1681\/ASN.2012030316","article-title":"Agalsidase benefits renal histology in young patients with Fabry disease","volume":"24","author":"C Tondel","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00428-011-1182-y","article-title":"Immunohistochemical diagnosis of Fabry nephropathy and localisation of globotriaosylceramide deposits in paraffin-embedded kidney tissue sections","volume":"460","author":"C Valbuena","year":"2012","journal-title":"Virchows Arch"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1529-8027.2011.00365.x","article-title":"Small fibers in Fabry disease: baseline and follow-up data under enzyme replacement therapy","volume":"16","author":"N \u00dc\u00e7eyler","year":"2011","journal-title":"J Peripher Nerv Syst"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"463","DOI":"10.7863\/jum.2012.31.3.463","article-title":"Cerebral blood flow in patients with Fabry disease as measured by Doppler sonography is not different from that in healthy individuals and is unaffected by treatment","volume":"31","author":"N \u00dc\u00e7eyler","year":"2012","journal-title":"J Ultrasound Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"e87054","DOI":"10.1371\/journal.pone.0087054","article-title":"Increased arterial diameters in the posterior cerebral circulation in men with fabry disease","volume":"9","author":"N \u00dc\u00e7eyler","year":"2014","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.pain.2003.12.024","article-title":"Development and validation of the Neuropathic Pain Symptom Inventory","volume":"108","author":"D Bouhassira","year":"2004","journal-title":"Pain"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1471-2377-11-104","article-title":"A modified score to identify and discriminate neuropathic pain: a study on the German version of the neuropathic pain symptom inventory (NPSI)","volume":"11","author":"C Sommer","year":"2011","journal-title":"BMC Neurol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1093\/brain\/awn093","article-title":"The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology","volume":"131","author":"G Devigili","year":"2008","journal-title":"Brain"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.pain.2006.01.041","article-title":"Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values","volume":"123","author":"R Rolke","year":"2006","journal-title":"Pain"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1093\/ndt\/gfp031","article-title":"Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy","volume":"24","author":"R Schiffmann","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1681\/ASN.2006121400","article-title":"Antiproteinuric Therapy and Fabry Nephropathy: Sustained Reduction of Proteinuria in Patients Receiving Enzyme Replacement Therapy with Agalsidase-beta","volume":"18","author":"H Tahir","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e598","DOI":"10.1371\/journal.pone.0000598","article-title":"Treatment of Fabry disease: outcome of a comparative trial with agalsidase alfa or beta at a dose of 0.2 mg\/kg","volume":"2","author":"AC Vedder","year":"2007","journal-title":"PLoS ONE"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1212\/WNL.45.10.1848","article-title":"Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy","volume":"45","author":"BG McCarthy","year":"1995","journal-title":"Neurology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1212\/WNL.0b013e3181e0f7b3","article-title":"Elevated proinflammatory cytokine expression in affected skin in small fiber neuropathy","volume":"74","author":"N \u00dc\u00e7eyler","year":"2010","journal-title":"Neurology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1468-1331.2005.01260.x","article-title":"EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy","volume":"12","author":"G Lauria","year":"2005","journal-title":"Eur J Neurol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"45200","DOI":"10.1074\/jbc.M303868200","article-title":"Two distinct Gb3\/CD77 signaling pathways leading to apoptosis are triggered by anti-Gb3\/CD77 mAb and verotoxin-1","volume":"278","author":"C Tetaud","year":"2003","journal-title":"J Biol Chem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/bjophthalmol-2014-306433","article-title":"Cornea verticillata supports a diagnosis of Fabry disease in non-classical phenotypes: results from the Dutch cohort and a systematic review","volume":"100","author":"L van der Tol","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1442-9071.2006.01318.x","article-title":"Immunofluorescence detection of globotriaosylceramide deposits in conjunctival biopsies of Fabry disease patients","volume":"34","author":"PA Rozenfeld","year":"2006","journal-title":"Clin Experiment Ophthalmol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1086\/318809","article-title":"A phase 1\/2 clinical trial of enzyme replacement in fabry disease: pharmacokinetic, substrate clearance, and safety studies","volume":"68","author":"CM Eng","year":"2001","journal-title":"Am J Hum Genet"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jpeds.2007.09.007","article-title":"Safety and efficacy of enzyme replacement therapy with agalsidase beta: an international, open-label study in pediatric patients with Fabry disease","volume":"152","author":"JE Wraith","year":"2008","journal-title":"J Pediatr"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ymgme.2014.08.007","article-title":"Chronic kidney disease and an uncertain diagnosis of Fabry disease: approach to a correct diagnosis","volume":"114","author":"L van der Tol","year":"2015","journal-title":"Mol Genet Metab"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/ana.410230513","article-title":"Nervous system involvement in Fabry's disease: clinicopathological and biochemical correlation","volume":"23","author":"EM Kaye","year":"1988","journal-title":"Ann Neurol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0166484","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T11:01:15Z","timestamp":1540033275000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0166484"}},"subtitle":[],"editor":[{"given":"Israel","family":"Silman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,11,16]]},"references-count":32,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2016,11,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0166484","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,16]]}}}